At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CTOR CITIUS ONCOLOGY INC
Market Closed 11-22 16:00:00 EST
0.8521
-0.1238
-12.69%
盘后0.9135
+0.0614+7.21%
19:45 EST
High1.01
Low0.8520
Vol89.44K
Open0.9859
D1 Closing0.9759
Amplitude16.05%
Mkt Cap60.76M
Tradable Cap4.48M
Total Shares71.30M
T/O82.23K
T/O Rate1.70%
Tradable Shares5.25M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Citius Pharmaceuticals reports positive early stage results of cancer combo treatment
TenX Keane Acquisition focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on target businesses operating in Asia, excluding companies located or operating in mainland China, Hong Kong, or Macau. The company was incorporated in 2021 and is based in New York, New York.